e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Translational studies in chronic repair and remodelling in the lung
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC 2013 abstract - NADPH oxidase isoform 2 (NOX2) is expressed in alveolar macrophages of emphysematous patients and prevents elastase-induced emphysema through the involvement of MMP9/TIMP1 gene expression
J. C. Pache, Y. Donati, C. Deffert, K. H. Krause, C. Barazzone-Argiroffo, S. Carnesecchi (Geneva, Switzerland)
Source:
Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung
Session:
Translational studies in chronic repair and remodelling in the lung
Session type:
Oral Presentation
Number:
3324
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. C. Pache, Y. Donati, C. Deffert, K. H. Krause, C. Barazzone-Argiroffo, S. Carnesecchi (Geneva, Switzerland). LSC 2013 abstract - NADPH oxidase isoform 2 (NOX2) is expressed in alveolar macrophages of emphysematous patients and prevents elastase-induced emphysema through the involvement of MMP9/TIMP1 gene expression. Eur Respir J 2013; 42: Suppl. 57, 3324
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
NADPH oxidase isoform 1 is expressed in lung tissue of ARDS patients and decreases hyperoxia-induced ROS production and cell death in pulmonary type II epithelial cells
Source: Annual Congress 2011 - Barrier functions in sepsis and acute lung injury
Year: 2011
Activation of membrane nadph oxidase in idiopathic pulmonary fibrosis (IPF) fibroblasts
Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair
Year: 2007
IL-4/13-induced up-regulation of METEORIN-LIKE (ML) in alveolar macrophages promotes epithelial CCR3 expression
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017
Differential expression of the S1P transporter, Spinster homologue 2 (Spns2), in airway epithelial cells and macrophages may drive defective macrophage function in COPD
Source: International Congress 2017 – Cigarette smoke and particulate matter: basic science and clinical aspects
Year: 2017
LSC 2013 abstract - The role of inducible nitric oxide synthase (iNOS) for the remodeling of alveolar septa in surfactant protein D deficient mice
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis
Year: 2013
Erythropoietin (EPO) inhibits the immunohistochemical expression of lysyl oxidase (LOX) in bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
NADPH oxidase 4 deficiency protects from bleomycin-induced epithelial cell death and pulmonary fibrosis
Source: Annual Congress 2010 - New insights into reactive oxygen species
Year: 2010
LSC - 2018 - Collagen-producing macrophages can mediate lung fibrosis throughFra-2/AP-1 expression
Source: International Congress 2018 – New insights in the signalling pathways that underlie IPF pathophysiology
Year: 2018
NADPH oxidase 4 signaling in a ventilator-induced lung injury mice model
Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine
Year: 2020
Hypoxia-dependent regulation of non-phagocytic NADPH oxidase NOX4 in the pulmonary vasculature
Source: Eur Respir J 2007; 30: Suppl. 51, 56s
Year: 2007
Fc gamma receptor III (FcγRIII) expression by alveolar macrophages is up-regulated by silica particles but is dispensable for silica-induced alveolitis in mice
Source: Eur Respir J 2007; 30: Suppl. 51, 368s
Year: 2007
Kaempferol-induced HO-1 expression attenuated inflammation in human pulmonary alveolar epithelial cells
Source: International Congress 2017 – Therapeutic approaches in lung disease
Year: 2017
Decreased expression of haem oxygenase-1 by alveolar macrophages in idiopathic pulmonary fibrosis
Source: Eur Respir J 2008; 31: 1030-1036
Year: 2008
A neo-epitope of serum lysyl oxidase like 2 (LOXL2) generated during enzyme maturation is elevated in cancer and idiopathic pulmonary disease
Source: International Congress 2017 – Techniques in biomarker selection
Year: 2017
LSC 2013 abstract - Mechanisms regulating enhanced alphavbeta6 expression in pulmonary fibrosis
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
Production of matrix metalloprotease-9 (MMP-9) by alveolar macrophages (AMs) from smokers: effect of corticosteroids and phosphodiesterase inhibition
Source: Eur Respir J 2001; 18: Suppl. 33, 34s
Year: 2001
Enhanced expression of Fas ligand (FasL) in fibrotic interstitial lung diseases (ILDs). The possible role of membrane-bound FasL form
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011
Human macrophage elastase (MMP-12) expression in human emphysematous lungs: role in extracellular matrix remodelling in chronic obstructive pulmonary diseases (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 501s
Year: 2001
Decreased mRNA and protein expression of peroxiredoxin (PRDX6) in the COPD lung
Source: Eur Respir J 2004; 24: Suppl. 48, 320s
Year: 2004
TGF-beta-dependent inhibitor of DNA protein (Id) expression in lung fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 521s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept